These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6246134)

  • 1. Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system.
    Gertner JM; Tamborlane WV; Horst RL; Sherwin RS; Felig P; Genel M
    J Clin Endocrinol Metab; 1980 May; 50(5):862-6. PubMed ID: 6246134
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased 1,25-dihydroxycholecalciferol as a cause of abnormal calcium metabolism in sarcoidosis.
    Koide Y; Kugai N; Kimura S; Fujita T; Yamashita N; Hiramoto ; Sukegawa J; Ogata E; Yamashita K
    J Clin Endocrinol Metab; 1981 Mar; 52(3):494-8. PubMed ID: 6257749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma 1.25 (OH)2D and PTH levels and urinary cyclic AMP response to exogenous PTH in PHP during childhood (author's transl)].
    Seino Y; Ishida M; Shimotsuji J; Ishii T; Matsuda S
    Horumon To Rinsho; 1979 Aug; 27(8):879-84. PubMed ID: 226296
    [No Abstract]   [Full Text] [Related]  

  • 4. Correction of abnormal bone and mineral metabolism in chronic streptozotocin-induced diabetes mellitus in the rat by insulin therapy.
    Hough S; Avioli LV; Bergfeld MA; Fallon MD; Slatopolsky E; Teitelbaum SL
    Endocrinology; 1981 Jun; 108(6):2228-34. PubMed ID: 6262054
    [No Abstract]   [Full Text] [Related]  

  • 5. Continuous intravenous insulin therapy with a miniaturized open-loop system.
    Renner R; Hepp KD; Mehnert H; Franetzki M
    Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preprogrammed insulin infusion with a portable pump system.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M
    Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-controlled portable insulin infusion pump in diabetics.
    Bojsen J; Deckert T; Kølendorf K; Lørup B
    Diabetes; 1979 Nov; 28(11):974-9. PubMed ID: 488546
    [No Abstract]   [Full Text] [Related]  

  • 8. A portable, pre-programmable insulin infusion system in diabetes mellitus.
    Kølendorf K; Bojsen J
    Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus.
    Stavljenić A; Granić M; Topić B; Skrabalo Z
    Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.
    Tamborlane WV; Sherwin RS; Genel M; Felig P
    N Engl J Med; 1979 Mar; 300(11):573-8. PubMed ID: 763270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects.
    Bilezikian JP; Canfield RE; Jacobs TP; Polay JS; D'Adamo AP; Eisman JA; DeLuca HF
    N Engl J Med; 1978 Aug; 299(9):437-41. PubMed ID: 210383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of growth hormone administration: reciprocal changes in serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption.
    Chipman JJ; Zerwekh J; Nicar M; Marks J; Pak CY
    J Clin Endocrinol Metab; 1980 Aug; 51(2):321-4. PubMed ID: 6249837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different insulin administration modalities on vitamin D metabolism of insulin-dependent diabetic patients.
    Colette C; Monnier L; Arnal J; Selam JL; Mirouze J
    Adv Exp Med Biol; 1986; 208():501-8. PubMed ID: 3551545
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute response of plasma 1,25-dihydroxyvitamin D to parathyroid hormone.
    Aarskog D; Aksnes L
    Lancet; 1980 Feb; 1(8164):362-3. PubMed ID: 6101809
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS; Svendsen PA; Deckert T
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission of insulin dependence induced by continuous subcutaneous insulin infusion (CSII) in type I, recent onset diabetics: role of beta cell recovery and lymphocyte subsets distribution.
    Guastamacchia E; Nardelli GM; Di Paolo S; Lattanzi V; Ciampolillo A; Lacasella R; Montedoro P; Giorgino R
    Diabete Metab; 1988; 14(2):138-9. PubMed ID: 3042488
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
    Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
    N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous predetermined infusion in insulin dependent diabetes in children and adolescents. A comparative study in relation to insulin infusion and duration of diabetes (author's transl)].
    Jean R; Rolin B; Viguier JL; Morel G; Branchet A
    Ann Pediatr (Paris); 1981 Sep; 28(7):485-92. PubMed ID: 7025729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.